Overview
Probiotic supplementation targeting the dysbiosis-thyroid axis aims to restore Lactobacillus and Bifidobacterium populations depleted in Hashimoto's thyroiditis, with potential downstream effects on iodine and selenium metabolism.
Mechanism
- Gut barrier restoration: Lactobacillus and Bifidobacterium strengthen tight junctions, reducing translocation of antigens that trigger molecular mimicry against thyroid peroxidase (TPO) and thyroglobulin
- Immune modulation: Probiotic-induced Treg expansion may dampen the Th1/Th17-driven autoimmune response targeting the thyroid
- Mineral metabolism: Gut microbiome composition influences absorption and bioavailability of iodine and selenium, both critical for thyroid hormone synthesis and antioxidant defense
Clinical Evidence
Currently in-progress. Small case series suggest benefit, but well-powered condition-specific RCTs are lacking. The mechanistic rationale is supported by established gut-thyroid axis literature.
Clinical Considerations
- Should be used alongside standard thyroid hormone replacement, not as a substitute
- Strain selection may matter: Lactobacillus and Bifidobacterium species with established immunomodulatory properties preferred
- Monitor thyroid function during supplementation — improved absorption of levothyroxine may necessitate dose adjustment